Concepedia

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia

Delphine Réa, Laurence Legros, Emmanuel Raffoux, Xavier Thomas, Pascal Turlure, Sébastien Maury, Brigitte Dupriez, Arnaud Pigneux, B Choufi, Oumédaly Reman,

Leukemia · 2006 · 76 citations · 13 references

DOI

Concepts

References

13

Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

Brian Druker, Charles L. Sawyers, Hagop M. Kantarjian et al. · New England Journal of Medicine · 2001 · 2.7K citations · Full text

, , +17

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

Moshe Talpaz · Blood · 2002 · 1K citations

, , +12

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

Deborah A. Thomas · Blood · 2003 · 569 citations

, , +11

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

Oliver G. Ottmann · Blood · 2002 · 554 citations · Full text

, , +12

Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial

Xavier Thomas, Jean-Michel Boiron, Françoise Huguet et al. · Journal of Clinical Oncology · 2004 · 545 citations · Full text

, , +12